Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'btk inhibitor 1 hydrochloride'

Search results for: 'btk inhibitor 1 hydrochloride'

Items 11-20 of 24

Page
per page
  1. SU11274
    A2678 SU11274
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,potent and selective
      ≥28.4 mg/mL
  2. NVP-BVU972
    A8489 NVP-BVU972
    Summary: C-Met inhibitor,potent and selective
      insoluble in H2O; ≥17 mg/mL
  3. JNJ-38877605
    A5092 JNJ-38877605
    Summary: C-Met inhibitor,ATP-competitive
      insoluble in H2O; ≥18.85 mg/mL
  4. PF-04217903 methanesulfonate
    A3712 PF-04217903 methanesulfonate
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      Soluble in DMSO
  5. Cabozantinib malate (XL184)
    B1401 Cabozantinib malate (XL184)
    Summary: MET andVEGF receptor2 inhibitor
      ≥31.8 mg/mL
  6. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
  7. PF-04217903
    A5096 PF-04217903
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥18.6 mg/mL
  8. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL
  9. BMS-794833
    B1438 BMS-794833
    Target: MET|Flk-1
    Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive
      ≥23.45 mg/mL
  10. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive

Items 11-20 of 24

Page
per page